Related Experiment Video
Updated: Apr 10, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
A Meta-Analysis of fMRI Activation Differences during Episodic Memory in Alzheimer's Disease and Mild Cognitive
Douglas P Terry1, Dean Sabatinelli1,2, A Nicolas Puente1
1Department of Psychology, University of Georgia, Athens, GA.
Abstract:
Functional MRI (fMRI) has the potential to be used as a tool to detect biomarkers related to classifying Alzheimer's disease (AD) and its prodromal stage, mild cognitive impairment (MCI). Previous meta-analyses suggest that during episodic memory tasks, MCI patients exhibit hyperactivation in the medial temporal lobe (MTL) while AD patients exhibit hypoactivation, compared to healthy older adults (HOAs). However, these previous studies have methodological weaknesses that limit the generalizability of the results. This quantitative meta-analysis re-examines the activation associated with episodic memory in AD and MCI as compared to cognitively normal populations to assess these commonly cited activation differences. A whole-brain activation likelihood estimation based meta-analysis was conducted on fMRI studies that examined episodic memory in HOA (n = 200), MCI (n = 131), and AD populations (n = 89; total n = 409). Diffuse activation was exhibited in the HOA sample, while activation was more limited in the clinical populations. Additionally, the HOA sample showed more activation in the right hippocampus compared to the AD sample. The MCI studies showed greater activation in the cerebellum compared to the HOA sample, potentially indicating a compensatory mechanism for verbal encoding. MTL hypoactivation in the AD sample is consistent with previous studies, but more evidence of MCI hyperactivation is needed before considering MTL activation as an early biomarker for the AD disease process.
Insights
Functional MRI (fMRI) shows distinct brain activation patterns in Alzheimer's disease (AD) and mild cognitive impairment (MCI). While AD patients exhibit medial temporal lobe (MTL) hypoactivation, MCI patients show varied activation, questioning its biomarker potential.
Area of Science:
- Neuroimaging
- Cognitive Neuroscience
- Biomarker Discovery
Background:
- Functional MRI (fMRI) shows potential for classifying Alzheimer's disease (AD) and mild cognitive impairment (MCI).
- Previous meta-analyses suggest differing medial temporal lobe (MTL) activation patterns in MCI and AD patients compared to healthy older adults (HOAs) during memory tasks.
- Methodological limitations in prior studies necessitate a re-evaluation of these findings.
Purpose of the Study:
- To quantitatively meta-analyze fMRI studies on episodic memory activation in HOAs, MCI, and AD populations.
- To assess commonly cited differences in brain activation between these groups.
- To evaluate the potential of MTL activation as an early biomarker for AD.
Main Methods:
- A whole-brain activation likelihood estimation (ALE) meta-analysis was performed.
- Included fMRI studies examined episodic memory in HOAs (n=200), MCI (n=131), and AD (n=89) populations (total n=409).
Main Results:
- Healthy older adults (HOAs) exhibited diffuse brain activation, while clinical populations showed more limited activation.
- HOAs had greater right hippocampal activation compared to the AD group.
- MCI patients showed increased cerebellar activation versus HOAs, suggesting a compensatory mechanism.
- AD patients displayed MTL hypoactivation, consistent with prior research.
Conclusions:
- While AD patients show MTL hypoactivation, the evidence for MCI hyperactivation as an early biomarker requires further investigation.
- Brain activation patterns during episodic memory tasks differ across healthy, MCI, and AD populations.
- fMRI activation patterns in MCI may indicate compensatory mechanisms rather than direct disease pathology in the MTL.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017